SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-046121
Filing Date
2011-08-11
Accepted
2011-08-11 16:02:11
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-14180_110q.htm 10-Q 879548
2 EX-31.1 a11-14180_1ex31d1.htm EX-31.1 11576
3 EX-31.2 a11-14180_1ex31d2.htm EX-31.2 11973
4 EX-32.1 a11-14180_1ex32d1.htm EX-32.1 5584
5 EX-32.2 a11-14180_1ex32d2.htm EX-32.2 5509
  Complete submission text file 0001104659-11-046121.txt   2606740

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tzym-20110630.xml EX-101.INS 274972
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tzym-20110630.xsd EX-101.SCH 12956
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tzym-20110630_cal.xml EX-101.CAL 31039
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tzym-20110630_def.xml EX-101.DEF 70725
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tzym-20110630_lab.xml EX-101.LAB 189676
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tzym-20110630_pre.xml EX-101.PRE 95291
Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 111027785
SIC: 2834 Pharmaceutical Preparations